Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forebrain Electroneutral Transporters in Salt-sensitive Hypertension
NCT06094816Phase 4Recruiting
- Sponsor
- University of Delaware
- Start
- Mar 2024
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of furosemide in hypertension (HTN), sponsored by University of Delaware. Started Mar 2024; status: recruiting.
02
Drugs
furosemide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06094816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06094816.